Hypertriglyceridemia: Clinical Trials

9 trials for Hypertriglyceridemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 29Terminated 9

Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
evinacumab, Placebo - Hypertriglyceridemia
Phase 2TerminatedRegeneron Pharmaceuticals212021-07-122024-05-22
Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
DS102, Placebo - Hypertriglyceridemia, Type 2 Diabetes
Phase 2TerminatedAfimmune2332020-10-132023-06-12
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
SLx-4090 placebo, Orlistat Placebo, Orlistat - Type 1 Hyperlipoproteinemia
Phase 2TerminatedUniversity of Texas Southwestern Medical Center52015-11-012021-08-19
Supplementation With Omega-3: Mechanism of Action
DHA-enriched, EPA-enriched - Hypertriglyceridemia
Phase 2TerminatedJohns Hopkins University132013-04-012017-03-01
Efficacy of LCQ908 on Cardiovascular Risk
pradigastat (LCQ908), Placebo - Coronary Artery Disease, Hypertriglyceridemia
Phase 2TerminatedNovartis Pharmaceuticals412011-12-012016-04-14
Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children
Omega Pure followed by placebo, Placebo followed by Omega Pure - Hypertriglyceridemia
Phase 2TerminatedThe Hospital for Sick Children132008-06-012014-06-12
Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides
Lovaza, Placebo - Hypertriglyceridemia
Phase 2TerminatedBoston Children's Hospital252008-04-012013-05-29
MK0859 Dose-Ranging Study (0859-003)
MK0859 - Hypercholesterolemia, Mixed Hyperlipemia
Phase 2TerminatedMerck Sharp & Dohme LLC5002006-06-012015-03-02
Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
implitapide - Hypertriglyceridemia
Phase 2TerminatedMedical Research Laboratories International502004-10-012005-06-24

Narrower conditions

Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Familial hyperchylomicronemia syndrome (1)  ·  Hypercholesterolemia (1)  ·  Hyperlipidemias (1)  ·  Hyperlipoproteinemia Type V (1)  ·  Pancreatitis (1)

Broader conditions

Dyslipidemias (9)  ·  Lipid Metabolism Disorders (9)  ·  Metabolic Diseases (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Hyperlipidemias (8)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Glucose Metabolism Disorders (1)

Interventions

6-(4'-trifluoromethyl-6-methoxybiphenyl-2-ylcarboxamido)-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid phenyl ester (1)  ·  Corn Oil (1)  ·  Omacor (1)  ·  Orlistat (1)  ·  anacetrapib (1)  ·  epeleuton (1)  ·  evinacumab (1)  ·  implitapide (1)  ·  pradigastat (1)

Sponsors

Afimmune (1)  ·  Boston Children's Hospital (1)  ·  Johns Hopkins University (1)  ·  Medical Research Laboratories International (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Novartis Pharmaceuticals (1)  ·  Regeneron Pharmaceuticals (1)  ·  The Hospital for Sick Children (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (7)  ·  Canada (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Georgia (1)  ·  Israel (1)  ·  Latvia (1)  ·  Norway (1)  ·  Switzerland (1)

Top investigators

Abhimanyu Garg, MD (1)  ·  Ari Bitnun, MD, MSc (1)  ·  Dhananjay Vaidya (1)  ·  Jason Brophy, MD (1)  ·  Markus Weissbach, MD (1)  ·  Sara DeFerranti, MD (1)  ·  Stanley Read, MD, PhD (1)  ·  Stavroula K Osganian, MD, ScD (1)

Results publications

PMID 21982664, PMID 25670366